Table 4.
List of the dosage, pharmacokinetics and side-effects of commonly prescribed TCAs and SSRIs for PE
| Drug | Dosage, mg | Metabolism | Half life | Side-effects |
|---|---|---|---|---|
| Clomipramine [,79] | 25 | CYP2C19, CYP3A4, CYP1A2 | 10–70 h | Manic episode in both bipolar and unipolar disorders. Anticholinergic side-effects: dry mouth, blurring of vision, constipation, urinary retention and aggravation of narrow-angle glaucoma. Cardiac side-effects including tachycardia, flattened T waves, prolonged QT intervals, and depressed ST segments |
| Fluoxetine [161,162] | 20–40 daily | CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 | 1–4 days | Dizziness, dry mouth, nausea, constipation, weight gain, insomnia, tremors, prolonged QT interval, light headedness, confusion, agitation, sexual dysfunction |
| Citalopram [163,164] | 20 | CYP2C19, CYP2D6, CYP3A4 | 35 h | |
| Escitalopram [165–168] | 10 | CYP2C19, CYP3A4 | 35 h | |
| Sertraline [79] | 25–50 | CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 | 26 h | |
| Paroxetine [73,74,169] | 20 | CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 | Variable depends on dose | |
| Fluvoxamine [79,170] | 50–300 | CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 | 15 h and 17 to 22 h |
|
| Dapoxetine [82,171] | 30 or 60 | CYP2D6, CYP3A4 | 1.4 and 20 h |